Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Clinical Trials Report for February 2015

    ... currently recruiting patients. Each has a specific purpose related to aplastic anemia , MDS, or PNH. Should you consider a ... of allogenic stem cell transplantation from either a matched unrelated donor or a mismatched reacted donor using the ...

    Page last updated 01/29/2015 - 10:10am.

  2. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... Must have a partially HLA matched UCB unit with a pre-cryopreserved TNC dose >2.5 x 107 per kilogram ... (e.g, second partially HLA matched UCB unit, haploidentical related donor). Voluntary written consent signed (adult or parental) before ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  3. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... Patient's < or = 75 years old with a 5/6 or 6/6 related donor match are eligible. Patient's < or = 75 years who have a 7-8/8 HLA -A,B,C,DRB1 allele matched unrelated volunteer marrow and/or peripheral blood stem cell (PBSC) ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  4. New York Blood Center National Cord Blood Program

    ... myeloid and platelet engraftment , transplant related mortality, overall survival, graft vs. host disease and, for patients ... Cord Blood Transplantation Other Name: One or more matched umbilical cord blood units for transplant ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  5. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. This is a pilot study, you are being ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  6. Intra-Osseous Co-Transplant of UCB and hMSC

    ... disease (e.g., myelodysplasia [MDS]) Treatment-related leukemia Complete remission (first complete remission [CR1]) with ... do not have human leukocyte antigen ( HLA )-matched (defined as matched in HLA A, B, C, and DRB1) related or unrelated ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  7. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... or, Myelodysplastic Syndrome (MDS): Primary or therapy related; or, Acute Lymphoblastic Leukemia (ALL): induction failure, primary ... Patients must have two CB units available which are matched with the patient at 4, 5, or 6/6 HLA class I (serological) and ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  8. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... an allogeneic hematopoietic stem cell transplantation from a related or unrelated HLA matched donor. The effect of 5-azacytidine on global gene methylation will ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  9. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. This is a pilot study, you are being ...

    Clinical Trial last updated 04/27/2016 - 1:04pm.

  10. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    ... to historical OS rates in similar populations after RIC matched donor HSCT as reported in the literature. SECONDARY OBJECTIVES: I. To compare the treatment-related mortality (TRM) rate at 2 years for patients treated on this study to ...

    Clinical Trial last updated 04/27/2016 - 1:56pm.